✅ Suggested content. Review the technical data and compliance, adjust whatever you need and delete this line before publishing.
Mazdutide is a dual agonist peptide that acts on the GLP-1 and glucagon receptors, known in the literature as IBI362 or OXM3. It belongs to the family of oxyntomodulin analogs studied in the metabolic field. NeoPeptidos offers it with ≥99% HPLC purity, for research use.
Technical profile
| Product | Mazdutide |
|---|---|
| CAS | 2259884-03-0 |
| Molecular formula | C₁₇₅H₂₆₈N₄₆O₅₆ |
| Molecular weight | 4019.55 Da |
| Sequence | Doble agonista GLP-1/GCG (29 aa) |
| Purity | 99% HPLC |
| Presentation | Lyophilized vial; bacteriostatic water included |
| Use | For scientific research use only |
What is Mazdutide?
Mazdutide is designed to activate two receptors at once: GLP-1 (linked to glucose and appetite) and glucagon (linked to energy expenditure). That dual action classifies it as a dual GLP-1/glucagon agonist within incretin peptides.
Research context
Mazdutide is the subject of metabolic research in ongoing preclinical and clinical studies on the regulation of glucose and body weight.
The NeoPeptidos product is research-grade material, not a clinical medicine; it includes no indications or administration schedules and is intended exclusively for researchers.
Handling and reconstitution
See the reconstitution guide and the storage guide.
Quality and traceability
≥99% purity by HPLC and batch COA. See quality control.
🔬 Updated on September 13, 2026 · Reviewed by the NeoPeptidos team · Content for research purposes (RUO).